SCHEMBL4901012

SCHEMBL4901012

COc1cc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)cc(OC)c1OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 7/20 0.74
PRKCD Q05655 4/20 0.74
PRKD3 O94806 2/20 0.74
PRKCG P05129 2/20 0.74
PRKCB P05771 2/20 0.74
PRKCH P24723 2/20 0.74
PRKCI P41743 2/20 0.74
PRKCE Q02156 2/20 0.74
PRKCQ Q04759 2/20 0.74
PRKCZ Q05513 2/20 0.74
PRKD1 Q15139 2/20 0.74
LCK P06239 1/20 0.74
ZAP70 P43403 1/20 0.74
ABL1 P00519 15/20 0.69
BCR P11274 15/20 0.69
PDGFRB P09619 5/20 0.64
PDGFRA P16234 5/20 0.64
EGFR P00533 1/20 0.64
SRC P12931 3/20 0.61
ABCB1 P08183 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903186 0.92 ABL1 (0.75) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4900131 0.90 PDGFRA (0.77) PRKCAABL1BCRPDGFRBPDGFRA
SCHEMBL4903320 0.90 ABL1 (0.61) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4903391 0.88 ABL1 (0.66) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL6976605 0.85 ZAP70 (1.00) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4891611 0.85 MEN1 (0.60) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL3997532 0.85 PRKCA (0.71) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4897346 0.85 ABL1 (0.67) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4892567 0.84 ABL1 (0.84) PRKCAPRKCDPRKD3PRKCGPRKCB
SCHEMBL4897378 0.83 ABL1 (0.64) PRKCAPRKCDPRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US claimed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP claimed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO claimed
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP PRKCA 2607/4885PRKCD 2034/4885PRKD3 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.